- Home
- ORKA vs MDXG Comparison
ORKA vs MDXG Comparison
Compare ORKA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- MDXG
- Stock Information
- Founded
- ORKA 2004
- MDXG 2006
- Country
- ORKA United States
- MDXG United States
- Employees
- ORKA N/A
- MDXG N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- ORKA Health Care
- MDXG Health Care
- Exchange
- ORKA Nasdaq
- MDXG Nasdaq
- Market Cap
- ORKA 1.0B
- MDXG 1.1B
- IPO Year
- ORKA N/A
- MDXG N/A
- Fundamental
- Price
- ORKA $22.62
- MDXG $9.42
- Analyst Decision
- ORKA Strong Buy
- MDXG Strong Buy
- Analyst Count
- ORKA 6
- MDXG 5
- Target Price
- ORKA $43.60
- MDXG $12.00
- AVG Volume (30 Days)
- ORKA 206.1K
- MDXG 781.2K
- Earning Date
- ORKA 11-13-2024
- MDXG 10-30-2024
- Dividend Yield
- ORKA N/A
- MDXG N/A
- EPS Growth
- ORKA N/A
- MDXG N/A
- EPS
- ORKA N/A
- MDXG 0.52
- Revenue
- ORKA N/A
- MDXG $342,804,000.00
- Revenue This Year
- ORKA N/A
- MDXG $9.56
- Revenue Next Year
- ORKA N/A
- MDXG $9.19
- P/E Ratio
- ORKA N/A
- MDXG $18.28
- Revenue Growth
- ORKA N/A
- MDXG 10.93
- 52 Week Low
- ORKA $18.20
- MDXG $5.47
- 52 Week High
- ORKA $53.88
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- MDXG 62.95
- Support Level
- ORKA N/A
- MDXG $9.07
- Resistance Level
- ORKA N/A
- MDXG $10.14
- Average True Range (ATR)
- ORKA 0.00
- MDXG 0.31
- MACD
- ORKA 0.00
- MDXG -0.11
- Stochastic Oscillator
- ORKA 0.00
- MDXG 41.67
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.